Increasing Demand Of Oncology Molecular Diagnostics Market In Emerging Economies

According to a recently published report the Oncology Molecular Diagnostics Market was estimated to grow around $1136.5 million by 2014 and it is forecasted to reach around $3391 million at the CAGR of 15% during 2015-2022. The segmentation of oncology molecular diagnostics market is based on product, test location, technology, type and geography. The report on Oncology Molecular Diagnostics Market Forecast 2015-2022 (by product, test location, technology, type and geography) provides detailed summary as well as forecasted analysis of the market.

Full report is available on global oncology based molecular diagnostics market forecast 2015-2022 (by product, test location, technology, type and geography)report at http://www.briskinsights.com/report/oncology-based-molecular-diagnostics-market

Rising demand of new technologies as well as technologicalupgradation are expected to boost the market during the forecasted period of the study. The global oncology molecular diagnostics Market is increasing at faster rate due to stringent rules and regulations and decreasing immunity level among consumers. The global Oncology Molecular Diagnostics Market is growing due to rising in awareness level of consumers regarding safety and health.The past few years has brought significant concerns for cancer treatment because ofincreasing number of cancer patients. There has been increasing requirement of molecular diagnostics equipments for oncology that helps in taking care of cancer patients and curing them. The rising concernregarding the cancer patients has forced to generate higher investment in the oncology molecular diagnostic market. Dietary and behavioral changes such as high consumption of tobacco, low intake of healthy food increases the chances forcancer all over the world. Some of the challenges faced by the oncology molecular diagnostics market are; huge capital investment in new technologies that requires high technical expertise; and lack of automation solutions is hindering the growth of Global Oncology Molecular Diagnostics Market.

Scope of the report

1. GLOBAL ONCOLOGY BASED MOLECULAR DIAGNOSTICS MARKET BY TYPE 2012 - 2022 ($ billion)
1.1. Breast cancer
1.2. Prostate cancer
1.3. Colorectal cancer
1.4. Cervical cancer
1.5. Liver cancer
1.6. Lung cancer
1.7. Blood cancer
1.8. Kidney cancer
1.9. Others

1. GLOBAL ONCOLOGY BASED MOLECULAR DIAGNOSTICS MARKET BY PRODUCT 2012 - 2022 ($ billion)
1.1. Instruments
1.2. Reagents
1.3. Others
2. GLOBAL ONCOLOGY BASED MOLECULAR DIAGNOSTICS MARKET BY 2012 - 2022 ($ billion)
2.1. Clinics and other establishments
2.2. Point of Care

3. GLOBAL ONCOLOGY BASEDMOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2022 ($ billion)
3.1. INDUSTRIAL WATER PROCESS
3.2. PCR
3.2.1. Multiplex
3.2.2. Others
3.3. In Situ Hybridization
3.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
3.5. Chips and microarrays
3.6. Mass spectrometry
3.7. Sequencing
3.8. Transcription Mediated Amplification
3.9. Others

4. GLOBAL ONCOLOGY BASED MOLECULAR DIAGNOSTICS MARKET REGIONAL OUTLOOK 2012-2022(in $billion)
4.1. North America
4.2. Europe
4.3. Asia Pacific
4.4. Rest of the World
5. COMPANY PROFILES

5.1. ABBOTT LABORATORIES
5.2. AUREON LABORATORIES

5.3. AUTOGENOMICS

5.4. BAYER HEALTHCARE
5.5. BECTION DICKINSON
5.6. CEPHEID
5.7. DAKO
5.8. DANAHER CORPORATION
5.9. GEN PROBE (HOLOGIC)
5.10. GENOMIC HEALTH INC.

5.11. QIAGEN N.V.
5.12. SIEMENS HEALTHCARE
5.13. SYSMEX CORPORATION
5.14. SKYLINE DIAGNOSTICS B.V.
5.15. TRIMGEN CORPORATION